RU2007139541A - Производные хромана и хромена и их применение - Google Patents
Производные хромана и хромена и их применение Download PDFInfo
- Publication number
- RU2007139541A RU2007139541A RU2007139541/04A RU2007139541A RU2007139541A RU 2007139541 A RU2007139541 A RU 2007139541A RU 2007139541/04 A RU2007139541/04 A RU 2007139541/04A RU 2007139541 A RU2007139541 A RU 2007139541A RU 2007139541 A RU2007139541 A RU 2007139541A
- Authority
- RU
- Russia
- Prior art keywords
- disorder
- compound
- independently selected
- drug
- compound according
- Prior art date
Links
- 0 *c(c(Cl)cc(F)c1)c1Cl Chemical compound *c(c(Cl)cc(F)c1)c1Cl 0.000 description 1
- QYDLKDJXJDEGNU-UHFFFAOYSA-N CC(C)Oc1cc(F)ccc1-c1cccc2c1OCCC2 Chemical compound CC(C)Oc1cc(F)ccc1-c1cccc2c1OCCC2 QYDLKDJXJDEGNU-UHFFFAOYSA-N 0.000 description 1
- DKKALGNRCHEZSU-HNNXBMFYSA-N CNC[C@H](CC1)Oc2c1cccc2-c(ccc(OC)c1)c1OC Chemical compound CNC[C@H](CC1)Oc2c1cccc2-c(ccc(OC)c1)c1OC DKKALGNRCHEZSU-HNNXBMFYSA-N 0.000 description 1
- HAXJKGYJQUUMQT-UHFFFAOYSA-N COc(c(-c1cccc2c1OCCC2)c1)ccc1F Chemical compound COc(c(-c1cccc2c1OCCC2)c1)ccc1F HAXJKGYJQUUMQT-UHFFFAOYSA-N 0.000 description 1
- FMXVKBORMCGMCQ-CQSZACIVSA-N COc(cc(CO)cc1)c1-c1cccc2c1O[C@@H](CN)CC2 Chemical compound COc(cc(CO)cc1)c1-c1cccc2c1O[C@@H](CN)CC2 FMXVKBORMCGMCQ-CQSZACIVSA-N 0.000 description 1
- FDGJBMXRNPBBNR-UHFFFAOYSA-N Cc(c(F)ccc1C(F)(F)F)c1-c1c2OCCCc2ccc1 Chemical compound Cc(c(F)ccc1C(F)(F)F)c1-c1c2OCCCc2ccc1 FDGJBMXRNPBBNR-UHFFFAOYSA-N 0.000 description 1
- NUECAIMJHZGLJO-UHFFFAOYSA-N Cc(cc1)cc(C)c1-c1c2OCCCc2ccc1 Chemical compound Cc(cc1)cc(C)c1-c1c2OCCCc2ccc1 NUECAIMJHZGLJO-UHFFFAOYSA-N 0.000 description 1
- IMYKXIZFHJRQCX-UHFFFAOYSA-N Cc(ccc(Cl)c1)c1-c1cccc2c1OC(CNC)CC2 Chemical compound Cc(ccc(Cl)c1)c1-c1cccc2c1OC(CNC)CC2 IMYKXIZFHJRQCX-UHFFFAOYSA-N 0.000 description 1
- NJABFUOBPLHAEP-CQSZACIVSA-N Cc1ccccc1-c1c2O[C@@H](CN)CCc2ccc1 Chemical compound Cc1ccccc1-c1c2O[C@@H](CN)CCc2ccc1 NJABFUOBPLHAEP-CQSZACIVSA-N 0.000 description 1
- IWUMAOVDGUODOR-UHFFFAOYSA-N Clc(cccc1)c1-c(c(OCCC1)c1cc1)c1Cl Chemical compound Clc(cccc1)c1-c(c(OCCC1)c1cc1)c1Cl IWUMAOVDGUODOR-UHFFFAOYSA-N 0.000 description 1
- UQSMQCNVGMWBFH-UHFFFAOYSA-N FC(Oc1cc(Cl)c(-c2c3OCCCc3ccc2)c(Cl)c1)(F)F Chemical compound FC(Oc1cc(Cl)c(-c2c3OCCCc3ccc2)c(Cl)c1)(F)F UQSMQCNVGMWBFH-UHFFFAOYSA-N 0.000 description 1
- NYMUBQPHHDEUHX-UHFFFAOYSA-N FC(c(cc1)cc(C(F)(F)F)c1-c1cccc2c1OCCC2)(F)F Chemical compound FC(c(cc1)cc(C(F)(F)F)c1-c1cccc2c1OCCC2)(F)F NYMUBQPHHDEUHX-UHFFFAOYSA-N 0.000 description 1
- SDIDHHZGSNWLLI-UHFFFAOYSA-N Fc(c(-c1c2OCCCc2ccc1)ccc1)c1Cl Chemical compound Fc(c(-c1c2OCCCc2ccc1)ccc1)c1Cl SDIDHHZGSNWLLI-UHFFFAOYSA-N 0.000 description 1
- QFMDNJYLJOILTK-UHFFFAOYSA-N Fc(cc1-c(c(Cl)ccc2)c2Cl)cc2c1OCCC2 Chemical compound Fc(cc1-c(c(Cl)ccc2)c2Cl)cc2c1OCCC2 QFMDNJYLJOILTK-UHFFFAOYSA-N 0.000 description 1
- CFSHFGMVRBSQBH-UHFFFAOYSA-N Fc(cc1-c2cccc(Cl)c2F)cc2c1OCCC2 Chemical compound Fc(cc1-c2cccc(Cl)c2F)cc2c1OCCC2 CFSHFGMVRBSQBH-UHFFFAOYSA-N 0.000 description 1
- BEDBEKQOWHFBSH-UHFFFAOYSA-N Fc1cc(-c(cccc2)c2Cl)c2OCCCc2c1 Chemical compound Fc1cc(-c(cccc2)c2Cl)c2OCCCc2c1 BEDBEKQOWHFBSH-UHFFFAOYSA-N 0.000 description 1
- NFPGLTLQGHDZHP-UHFFFAOYSA-N Fc1cc(-c2cc(Cl)ccc2Cl)c2OCC=Cc2c1 Chemical compound Fc1cc(-c2cc(Cl)ccc2Cl)c2OCC=Cc2c1 NFPGLTLQGHDZHP-UHFFFAOYSA-N 0.000 description 1
- RUUUQPPDFREKIY-UHFFFAOYSA-N Fc1cc(-c2cc(Cl)ccc2Cl)c2OCCCc2c1 Chemical compound Fc1cc(-c2cc(Cl)ccc2Cl)c2OCCCc2c1 RUUUQPPDFREKIY-UHFFFAOYSA-N 0.000 description 1
- UYLCJDYFIPWSKM-UHFFFAOYSA-N NCC(C=C1)Oc(c(-c2ccccc2Cl)c2)c1cc2F Chemical compound NCC(C=C1)Oc(c(-c2ccccc2Cl)c2)c1cc2F UYLCJDYFIPWSKM-UHFFFAOYSA-N 0.000 description 1
- OFZCOFFIXMJCHI-UHFFFAOYSA-N NCC(CC1)Oc2c1cccc2-c1ccccc1 Chemical compound NCC(CC1)Oc2c1cccc2-c1ccccc1 OFZCOFFIXMJCHI-UHFFFAOYSA-N 0.000 description 1
- BNXPDLFCGJFNOG-LLVKDONJSA-N NC[C@@H](CC1)Oc2c1cccc2-c(c(Cl)ccc1)c1Cl Chemical compound NC[C@@H](CC1)Oc2c1cccc2-c(c(Cl)ccc1)c1Cl BNXPDLFCGJFNOG-LLVKDONJSA-N 0.000 description 1
- SORWPBVJFRBEQF-AWEZNQCLSA-N NC[C@H](CC1)Oc(c(-c2ccccc2)c2)c1cc2F Chemical compound NC[C@H](CC1)Oc(c(-c2ccccc2)c2)c1cc2F SORWPBVJFRBEQF-AWEZNQCLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67382005P | 2005-04-22 | 2005-04-22 | |
US60/673,820 | 2005-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007139541A true RU2007139541A (ru) | 2009-05-27 |
Family
ID=36888961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007139541/04A RU2007139541A (ru) | 2005-04-22 | 2006-04-21 | Производные хромана и хромена и их применение |
Country Status (19)
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
GT200600161A (es) * | 2005-04-22 | 2007-03-14 | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途 |
PE20061297A1 (es) * | 2005-04-22 | 2006-12-24 | Wyeth Corp | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c |
EP1871759A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth a Corporation of the State of Delaware | Benzodioxane and benzodioxolane derivatives and uses thereof |
EP1871355A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth | New therapeutic combianations for the treatment or prevention of depression |
JP2008538577A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
JP2008538578A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | 疼痛の治療 |
CN101175740A (zh) * | 2005-04-22 | 2008-05-07 | 惠氏公司 | 二氢苯并呋喃衍生物和其用途 |
BRPI0609988A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | derivados de diidrobenzofurano e usos dos mesmos |
CA2606064A1 (en) * | 2005-04-24 | 2006-11-02 | Wyeth | Methods for modulating bladder function |
WO2007112065A2 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for treating cognitive and other disorders |
TW200815388A (en) * | 2006-04-18 | 2008-04-01 | Wyeth Corp | Chromane and chromene derivatives and uses thereof |
EP2742936A1 (en) | 2006-05-16 | 2014-06-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
CL2007003043A1 (es) * | 2006-10-24 | 2008-05-30 | Wyeth Corp | Compuestos derivados de cromano; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y ansiedad entre otros. |
PE20081139A1 (es) * | 2006-10-25 | 2008-09-18 | Wyeth Corp | Derivados de cromano, su sintesis e intermediarios |
RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
US8914112B2 (en) | 2008-01-23 | 2014-12-16 | Boston Scienctific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain caused by sphincter of Oddi dysfunction |
US8676322B2 (en) | 2008-01-30 | 2014-03-18 | Boston Scientific Neuromodulation Corporation | Methods and systems of treating pancreatitis pain |
JP2010043063A (ja) | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
PL3085381T3 (pl) | 2008-05-21 | 2018-09-28 | Ferring B.V. | Ulegająca rozpadowi w ustach desmopresyna do zwiększania okresu snu niezakłócanego przez nokturię |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
CN101921252B (zh) * | 2010-07-02 | 2012-05-09 | 中国科学院上海有机化学研究所 | 1-氧杂苯并杂环类化合物、合成方法和用途 |
RU2549543C2 (ru) | 2010-12-21 | 2015-04-27 | Колгейт-Палмолив Компани | Галогенированные бифенолы в качестве антибактериальных средств |
MY195032A (en) * | 2012-12-18 | 2023-01-04 | Dsm Ip Assets Bv | (6R,10R)-6,10,14-Trimetylpentadecan-2-One Prepared From (R)-6,10,14-Trimetylpentadec-5-en-2-One |
KR101592560B1 (ko) * | 2013-06-21 | 2016-02-05 | 제주대학교 산학협력단 | 신규 플라보노이드 및 그 용도 |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
EA201791804A1 (ru) | 2015-02-11 | 2018-02-28 | Суновион Фармасьютикалз Инк. | Соединения 1-гетероциклил изохроманила и аналоги для лечения расстройств цнс |
BR112019001407A2 (pt) | 2016-07-29 | 2019-07-09 | Pgi Drug Discovery Llc | compostos e composições e usos dos mesmos |
US10196403B2 (en) | 2016-07-29 | 2019-02-05 | Sunovion Pharmaceuticals Inc. | Compounds and compositions and uses thereof |
JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE |
EP3923919A4 (en) * | 2019-02-17 | 2022-12-07 | Neurawell Therapeutics | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION AND OTHER DISORDERS |
JP2022525169A (ja) | 2019-03-14 | 2022-05-11 | サノビオン ファーマシューティカルズ インク | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1262078A (en) | 1968-05-24 | 1972-02-02 | Fisons Pharmaceuticals Ltd | Preparation of phenoxy fumaric acid compounds and chromone-2-carboxylic acid compounds therefrom |
US4536518A (en) | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US4654362A (en) | 1983-12-05 | 1987-03-31 | Janssen Pharmaceutica, N.V. | Derivatives of 2,2'-iminobisethanol |
GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US5089637A (en) | 1990-03-21 | 1992-02-18 | Pfizer Inc. | Process and intermediates for 2r-benzyl-chroman-6-carbaldehyde |
JP3283114B2 (ja) | 1992-09-07 | 2002-05-20 | クミアイ化学工業株式会社 | 縮合ヘテロ環誘導体及び農園芸用殺菌剤 |
US5731324A (en) | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
PL181385B1 (pl) | 1993-08-19 | 2001-07-31 | Janssen Pharmaceutica Nv | Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL |
US6150402A (en) | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
DE4430089A1 (de) | 1994-08-25 | 1996-02-29 | Bayer Ag | Verfahren zur enzymatischen Herstellung von enantiomerenreinen Chroman-2-carbonsäuren und deren Derivaten |
PT707007E (pt) | 1994-10-14 | 2002-06-28 | Merck Patent Gmbh | Derivados amino(tio)eter como agentes activos no snc |
US5658796A (en) | 1995-06-07 | 1997-08-19 | Seprachem, Inc. | Optical resolution of alkyl chroman-2-carboxylates |
PT971878E (pt) | 1997-02-27 | 2008-07-08 | Takeda Pharmaceutical | Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta |
FR2763335B1 (fr) | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6133277A (en) | 1997-12-05 | 2000-10-17 | Janssen Pharmaceutica N.V. | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
US20060258176A1 (en) * | 1998-02-05 | 2006-11-16 | Asm Japan K.K. | Method for forming insulation film |
US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
FR2791675B1 (fr) | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique |
DE10044091A1 (de) | 2000-09-07 | 2002-04-04 | Merck Patent Gmbh | Chromanonderivate |
US20040029788A1 (en) | 2000-11-01 | 2004-02-12 | Hans-Markus Bender | Methods and compositions for the treatment of diseases of the eye |
DE10120619A1 (de) | 2001-04-26 | 2002-10-31 | Merck Patent Gmbh | 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman |
MXPA04000839A (es) | 2001-08-01 | 2004-05-14 | Merck Patent Gesellscahft Mit | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. |
WO2003029239A1 (en) | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
CA2461381A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman derivatives as 5-hydroxytryptamine-6 ligands |
BR0213127A (pt) | 2001-10-05 | 2004-09-21 | Wyeth Corp | Processo para a sìntese estéreo-seletiva de 2-hidroximetil-cromanos |
MXPA04003085A (es) | 2001-10-05 | 2004-09-06 | Wyeth Corp | Proceso estereoespecifico para sintesis de derivados de 2-il cromano. |
WO2003031439A1 (en) | 2001-10-05 | 2003-04-17 | Wyeth | Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
JPWO2003040382A1 (ja) | 2001-11-09 | 2005-03-03 | 株式会社カネカ | 光学活性クロマン誘導体の製造法および中間体 |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
WO2004045534A2 (en) | 2002-11-15 | 2004-06-03 | Galileo Pharmaceuticals, Inc. | Chroman derivatives for the reduction of inflammation symptoms |
CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
DE10348257A1 (de) | 2003-10-16 | 2005-05-25 | Merck Patent Gmbh | Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US7728155B2 (en) * | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
DE102004011265A1 (de) | 2004-03-09 | 2005-09-29 | Lutz F. Prof. Dr. Tietze | Synthese von Vitamin E |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
AU2005316972B2 (en) | 2004-11-24 | 2011-11-10 | Abbvie Inc. | Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
PE20061297A1 (es) * | 2005-04-22 | 2006-12-24 | Wyeth Corp | Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c |
JP2008538581A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | {[(2r)−7−(2,6−ジクロロフェニル)−5−フルオロ−2,3−ジヒドロ−1−ベンゾフラン−2−イル]メチル}アミン塩酸塩の結晶形態 |
EP1871759A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth a Corporation of the State of Delaware | Benzodioxane and benzodioxolane derivatives and uses thereof |
GT200600161A (es) * | 2005-04-22 | 2007-03-14 | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途 |
BRPI0609988A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | derivados de diidrobenzofurano e usos dos mesmos |
EP1898895A2 (en) * | 2005-04-22 | 2008-03-19 | Wyeth | Treatment of drug abuse |
EP1871355A1 (en) * | 2005-04-22 | 2008-01-02 | Wyeth | New therapeutic combianations for the treatment or prevention of depression |
JP2008538578A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | 疼痛の治療 |
JP2008538577A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
CA2606064A1 (en) * | 2005-04-24 | 2006-11-02 | Wyeth | Methods for modulating bladder function |
-
2006
- 2006-04-21 PE PE2006000415A patent/PE20061297A1/es not_active Application Discontinuation
- 2006-04-21 US US11/409,467 patent/US7365095B2/en not_active Expired - Fee Related
- 2006-04-21 AR ARP060101590A patent/AR056320A1/es unknown
- 2006-04-21 CN CNA2006800222674A patent/CN101203505A/zh active Pending
- 2006-04-21 KR KR1020077027247A patent/KR20080008378A/ko not_active Application Discontinuation
- 2006-04-21 WO PCT/US2006/015208 patent/WO2006116165A1/en active Application Filing
- 2006-04-21 TW TW095114313A patent/TW200716595A/zh unknown
- 2006-04-21 BR BRPI0610027-9A patent/BRPI0610027A2/pt not_active Application Discontinuation
- 2006-04-21 MX MX2007013163A patent/MX2007013163A/es unknown
- 2006-04-21 RU RU2007139541/04A patent/RU2007139541A/ru unknown
- 2006-04-21 GT GT200600166A patent/GT200600166A/es unknown
- 2006-04-21 JP JP2008507952A patent/JP2008538576A/ja active Pending
- 2006-04-21 CA CA002605587A patent/CA2605587A1/en not_active Abandoned
- 2006-04-21 AU AU2006239937A patent/AU2006239937A1/en not_active Abandoned
- 2006-04-21 EP EP06758490A patent/EP1874756A1/en not_active Withdrawn
-
2007
- 2007-10-19 ZA ZA200709052A patent/ZA200709052B/xx unknown
- 2007-10-22 IL IL186837A patent/IL186837A0/en unknown
- 2007-10-22 CO CO07110959A patent/CO6321153A2/es not_active Application Discontinuation
- 2007-11-06 NO NO20075641A patent/NO20075641L/no not_active Application Discontinuation
-
2008
- 2008-03-19 US US12/051,368 patent/US20080182891A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CO6321153A2 (es) | 2011-09-20 |
NO20075641L (no) | 2007-11-20 |
KR20080008378A (ko) | 2008-01-23 |
ZA200709052B (en) | 2009-08-26 |
JP2008538576A (ja) | 2008-10-30 |
CA2605587A1 (en) | 2006-11-02 |
TW200716595A (en) | 2007-05-01 |
IL186837A0 (en) | 2008-02-09 |
AR056320A1 (es) | 2007-10-03 |
EP1874756A1 (en) | 2008-01-09 |
US7365095B2 (en) | 2008-04-29 |
CN101203505A (zh) | 2008-06-18 |
PE20061297A1 (es) | 2006-12-24 |
US20080182891A1 (en) | 2008-07-31 |
MX2007013163A (es) | 2008-01-21 |
GT200600166A (es) | 2007-03-14 |
WO2006116165A1 (en) | 2006-11-02 |
BRPI0610027A2 (pt) | 2010-05-18 |
US20060258714A1 (en) | 2006-11-16 |
AU2006239937A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007139541A (ru) | Производные хромана и хромена и их применение | |
RU2007139543A (ru) | Производные бензодиоксана и бензодиоксолана и их применение | |
RU2020123764A (ru) | Органические соединения | |
RU2018130727A (ru) | Органические соединения | |
RU2016143091A (ru) | Органические соединения | |
JP2006143749A5 (US20060258714A1-20061116-C00123.png) | ||
JP2008536946A (ja) | うつ病の処置または予防のための新規の治療的組み合わせ | |
AP2002002481A0 (en) | Biaryl ether derivatives useful as monoamine reuptake inhibitors. | |
JP2008538577A (ja) | ジヒドロベンゾフラン誘導体およびその使用 | |
RU2006140964A (ru) | Применение флибансерина для лечения предменструальных и иных сексуальных расстройств у женщин | |
CO5190662A1 (es) | Inhibidores altamente selectivos de la recaptacion de la norepinefrina y metodos de uso de los mismos | |
BRPI0610028A2 (pt) | combinações terapêuticas para o tratamento ou a prevenção de distúrbios psicóticos | |
JP2002523506A5 (US20060258714A1-20061116-C00123.png) | ||
NZ580801A (en) | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | |
NZ548926A (en) | Inhibitors of TGF-R signaling for treatment of CNS disorders | |
RU2006107534A (ru) | Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства | |
US20220220062A1 (en) | Synthetic methods of preparing esketamine | |
RU2004112546A (ru) | Частичная агонистическая активность в отношении d2 рецепторов допамина и/или ингибирующая активность в отношении норадреналина | |
JP2011518858A5 (US20060258714A1-20061116-C00123.png) | ||
BR0317422A (pt) | Compostos de n-(indoletil) cicloamina | |
JP2018508556A5 (US20060258714A1-20061116-C00123.png) | ||
CN102026988B (zh) | 3-取代的丙胺化合物 | |
RU2017134796A (ru) | Органические соединения | |
RU2007105494A (ru) | Средство для содействия восстановлению при дисфункции после начала центрального неврологического заболевания | |
JP2011518859A5 (US20060258714A1-20061116-C00123.png) |